Jing‐Min Hwang

706 total citations
23 papers, 534 citations indexed

About

Jing‐Min Hwang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Jing‐Min Hwang has authored 23 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Organic Chemistry. Recurrent topics in Jing‐Min Hwang's work include Synthesis and biological activity (4 papers), Advanced Radiotherapy Techniques (4 papers) and Head and Neck Cancer Studies (4 papers). Jing‐Min Hwang is often cited by papers focused on Synthesis and biological activity (4 papers), Advanced Radiotherapy Techniques (4 papers) and Head and Neck Cancer Studies (4 papers). Jing‐Min Hwang collaborates with scholars based in Taiwan, United States and Japan. Jing‐Min Hwang's co-authors include Chien‐Yuan Chen, Yee‐Min Jen, Hsing‐Lung Chao, Chun‐Shu Lin, Dai‐Wei Liu, Wen‐Lin Hsu, Ming‐Fang Cheng, Yaoh-Shiang Lin, Meilan Huang and Hsu‐Shan Huang and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Clinical Chemistry and Analytica Chimica Acta.

In The Last Decade

Jing‐Min Hwang

21 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing‐Min Hwang Taiwan 11 188 129 124 121 86 23 534
Przemysław Koźmiński Poland 13 150 0.8× 82 0.6× 66 0.5× 64 0.5× 122 1.4× 37 661
Victor Sokolov Russia 16 114 0.6× 124 1.0× 175 1.4× 7 0.1× 196 2.3× 65 601
Markus Fischer Germany 13 180 1.0× 153 1.2× 43 0.3× 147 1.2× 92 1.1× 39 726
Geena Jung United States 15 247 1.3× 132 1.0× 15 0.1× 27 0.2× 83 1.0× 43 689
Pierre Bohn France 18 129 0.7× 44 0.3× 64 0.5× 13 0.1× 234 2.7× 42 774
Shujun Xia China 19 350 1.9× 66 0.5× 128 1.0× 4 0.0× 49 0.6× 56 871
Maximilian Baumgartner Germany 13 89 0.5× 74 0.6× 25 0.2× 11 0.1× 22 0.3× 31 376
T. Taguchi Japan 10 227 1.2× 62 0.5× 14 0.1× 16 0.1× 161 1.9× 35 610
Pei-Ying Hsieh Taiwan 11 117 0.6× 30 0.2× 79 0.6× 11 0.1× 19 0.2× 22 397
Ruth Jacobs United Kingdom 8 199 1.1× 9 0.1× 37 0.3× 5 0.0× 49 0.6× 12 462

Countries citing papers authored by Jing‐Min Hwang

Since Specialization
Citations

This map shows the geographic impact of Jing‐Min Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing‐Min Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing‐Min Hwang more than expected).

Fields of papers citing papers by Jing‐Min Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing‐Min Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing‐Min Hwang. The network helps show where Jing‐Min Hwang may publish in the future.

Co-authorship network of co-authors of Jing‐Min Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Jing‐Min Hwang. A scholar is included among the top collaborators of Jing‐Min Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing‐Min Hwang. Jing‐Min Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Wei‐Chou, Cheng‐Hsiang Lo, Jen-Fu Yang, et al.. (2021). Using computed tomography-based radiomics to predict outcomes for hepatocellular carcinoma patients receiving stereotactic body radiotherapy. 5. 13–13. 1 indexed citations
2.
Hwang, Jing‐Min, et al.. (2018). Use of electronic portal images to evaluate setup error and intra-fraction motion during free-breathing breast IMRT treatment. Medical dosimetry. 44(3). 233–238. 4 indexed citations
3.
Hwang, Jing‐Min, et al.. (2016). Optimal technique of linear accelerator–based stereotactic radiosurgery for tumors adjacent to brainstem. Medical dosimetry. 41(3). 248–252.
4.
Lin, Hon‐Yi, Yee‐Min Jen, Dai‐Wei Liu, et al.. (2008). The Role of Primary Surgery in Resectable Stage III/IV Tonsillar Carcinoma. Tzu Chi Medical Journal. 20(1). 49–57.
5.
Lin, Chun‐Shu, et al.. (2006). Treatment of Portal Vein Tumor Thrombosis of Hepatoma Patients with Either Stereotactic Radiotherapy or Three-Dimensional Conformal Radiotherapy. Japanese Journal of Clinical Oncology. 36(4). 212–217. 68 indexed citations
6.
Jen, Yee‐Min, Yaoh‐Shiang Lin, Wan‐Fu Su, et al.. (2005). Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: A dosimetric and clinical comparison with conventional radiotherapy. Radiotherapy and Oncology. 75(2). 204–209. 25 indexed citations
7.
Lin, Chun‐Shu, Yee‐Min Jen, Ming‐Fang Cheng, et al.. (2005). Squamous cell carcinoma of the buccal mucosa: An aggressive cancer requiring multimodality treatment. Head & Neck. 28(2). 150–157. 93 indexed citations
8.
Hsu, Wen‐Lin, et al.. (2004). Synthesis and Biological Activity of Sulfur‐Containing Aryl‐Aldehyde Schiff Bases.. ChemInform. 35(16). 1 indexed citations
9.
Hwang, Jing‐Min, et al.. (2003). Development of an immunosensor for human ferritin, a nonspecific tumor marker, based on surface plasmon resonance. Biosensors and Bioelectronics. 19(9). 999–1005. 73 indexed citations
10.
Hwang, Jing‐Min, et al.. (2003). Effects of oral arginine and glutamine on radiation-induced injury in the rat. Journal of Surgical Research. 109(2). 149–154. 35 indexed citations
11.
Chang, Tsu‐Chung, et al.. (2003). Synthesis and Biological Evaluation of Ebselen and Its Acyclic Derivatives. Chemical and Pharmaceutical Bulletin. 51(12). 1413–1416. 32 indexed citations
12.
Hsu, Wen‐Lin, et al.. (2003). Synthesis and Biological Activity of Sulfur-Containing Aryl-aldehyde Schiff Bases. Chemical and Pharmaceutical Bulletin. 51(11). 1307–1310. 15 indexed citations
13.
Hsu, Wen‐Lin, et al.. (2002). Production of Monoclonal and Polyclonal Antibodies against Human Alphafetoprotein, a Hepatocellular Tumor Marker. PubMed. 21(4). 301–305. 5 indexed citations
14.
Jen, Yee‐Min, Yaoh‐Shiang Lin, Wan‐Fu Su, et al.. (2002). Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?. International Journal of Radiation Oncology*Biology*Physics. 54(1). 14–22. 28 indexed citations
15.
Hwang, Jing‐Min, et al.. (2002). Development of an immunosensor for human ferritin, a nonspecific tumor marker, based on a quartz crystal microbalance. Analytica Chimica Acta. 453(2). 181–189. 32 indexed citations
16.
Huang, Hsu‐Shan, et al.. (2001). Chromophore-Modified Antitumor Anthracenes. 1. Cytotoxic Activity of 9-Acyloxy 1,5-Dichloroanthracene Analogues. Zhōnghuá yàoxué zázhì. 53(2). 71–83. 2 indexed citations
17.
Huang, Hsu‐Shan, et al.. (2001). Studies on Anthracenes. 2. Synthesis and Cytotoxic Evaluation of 9-Acyloxy 1,8-Dichloroanthracene Derivatives.. Chemical and Pharmaceutical Bulletin. 49(10). 1346–1348. 10 indexed citations
18.
Huang, Hsu‐Shan, et al.. (2001). Studies on Anthracenes. 1. Human Telomerase Inhibition and Lipid Peroxidation of 9-Acyloxy 1,5-Dichloroanthracene Derivatives.. Chemical and Pharmaceutical Bulletin. 49(8). 969–973. 22 indexed citations
19.
Chen, Chang‐Ming, et al.. (1998). Radiotherapy in the Treatment of Paranasal Sinuses Cancer-The Experience of Tri-Service General Hospital. 5(3). 171–177. 1 indexed citations
20.
Shueng, Pei‐Wei, et al.. (1996). Concurrent 5-Fluorouracil, Daily Low-Dose Cisplatin, and Radiotherapy in Stage IIIB Cervical Cancer. American Journal of Clinical Oncology. 19(3). 263–267. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026